InvestorLens

CPRX — CATALYST PHARMACEUTICALS INC

Public company

Sign in to save3 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying CPRX?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
50
Institutional Conviction
Net distribution · 2 buying vs 2 selling last quarter
40
Macro Tailwind
Macro conditions are mixed for this sector
57
Why? — Evidence & Confidence ▾

Of 4 tracked investors who changed their CPRX position last quarter, 2 bought and 2 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).

Supporting evidence
  • +2 tracked investors added or increased positions last quarter (Izzy Englander, George Soros)
  • +3 tracked investors reported holding CPRX at their latest filing
  • +Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource
Contradicting evidence — always shown
  • −2 tracked investors reduced or exited last quarter (0 reduced, 2 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.

About CATALYST PHARMACEUTICALS INC (CPRX)

CATALYST PHARMACEUTICALS INC (CPRX) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $34M. Across recent filings, tracked investors recorded 9 new positions, 4 increased, 3 reduced, and 6 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CPRX

59
/100
Mixed Activity
Added / Increased13
Reduced3
Exited6
BearishBullish
Crowded Trade Score™

How many top investors track CPRX

20
/100
Emerging Interest
3investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

CPRX Ownership Composition

How CATALYST PHARMACEUTICALS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
77% of tracked value
Institutions
3
tracked investors
Total Reported
$47.5M
combined 13F value
Types2
  • Multi-Strategy / Quant77.2%
  • Macro22.8%
Multi-Strategy / Quant(2)
77.2%
Macro(1)
22.8%

Tracked investors currently reporting CPRX

2 tracked investors have since exited this position — listed separately below.

  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    1.1M
    Value
    $33.6M
    % Portfolio
    0.01%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    96.6K
    Value
    $3M
    % Portfolio
    0.00%
  • George SorosJun 30, 2026
    Soros Fund Management
    Shares
    344.6K
    Value
    $10.8M
    % Portfolio
    0.13%

Previously held CPRX

These investors reported CPRX in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Steve CohenPoint72 Asset Management425.9K$10.5MMar 31, 2026
Paul Tudor JonesTudor Investment Corp20.4K$505KMar 31, 2026

Recent activity

Frequently asked questions

How many institutional investors hold CPRX?
3 tracked institutional investors disclosed a position in CPRX (CATALYST PHARMACEUTICALS INC) in their most recent 13F filing.
Who is the largest institutional holder of CPRX?
Izzy Englander, Millennium Management, holds the largest disclosed position in CPRX, valued at $34M.
Did institutional ownership of CPRX increase or decrease?
Across recent 13F filings, tracked investors recorded 9 new positions, 4 increased, 3 reduced, and 6 fully exited CPRX.
Where does this CPRX ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.